Evercore ISI analyst Gavin Clark-Gartner raised the firm’s price target on Argenx (ARGX) to $1,059 from $1,007 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Argenx price target raised to $1,016 from $1,013 at BofA
- Myles Minter Reiterates Buy as Vyvgart’s Expanded FDA Label and Attractive Valuation Support Continued Growth
- Argenx: FDA approves label expansion for Vyvgart, Vvygart Hytrulo
- Argenx price target lowered to $1,170 from $1,230 at Morgan Stanley
- Argenx price target raised to $1,135 from $1,120 at Guggenheim